Cedar Mountain Advisors’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-573
| Closed | -$9K | – | 329 |
|
|
2023
Q2 | $9K | Hold |
573
| – | – | ﹤0.01% | 174 |
|
|
2023
Q1 | $9.44K | Hold |
573
| – | – | ﹤0.01% | 168 |
|
|
2022
Q4 | $8.94K | Hold |
573
| – | – | ﹤0.01% | 169 |
|
|
2022
Q3 | $7K | Hold |
573
| – | – | ﹤0.01% | 190 |
|
|
2022
Q2 | $8K | Hold |
573
| – | – | ﹤0.01% | 183 |
|
|
2022
Q1 | $8K | Hold |
573
| – | – | ﹤0.01% | 202 |
|
|
2021
Q4 | $8K | Hold |
573
| – | – | ﹤0.01% | 199 |
|
|
2021
Q3 | $9K | Hold |
573
| – | – | ﹤0.01% | 180 |
|
|
2021
Q2 | $10K | Hold |
573
| – | – | ﹤0.01% | 168 |
|
|
2021
Q1 | $10K | Hold |
573
| – | – | ﹤0.01% | 177 |
|
|
2020
Q4 | $10K | Hold |
573
| – | – | ﹤0.01% | 176 |
|
|
2020
Q3 | $10K | Hold |
573
| – | – | ﹤0.01% | 163 |
|
|
2020
Q2 | $10K | Hold |
573
| – | – | ﹤0.01% | 155 |
|
|
2020
Q1 | $9K | Hold |
573
| – | – | ﹤0.01% | 130 |
|
|
2019
Q4 | $11K | Buy |
+573
| New | +$11K | ﹤0.01% | 133 |
|